Transcatheter valve-in-valve implantation due to severe aortic regurgitation in a degenerated aortic homograft
Research output: Contribution to journal › Journal article › Research › peer-review
Transcatheter aortic valve implantation (TAVI) in severe aortic stenosis has proven to be a feasible and effective treatment modality for inoperable patients. Until now, neither aortic regurgitation nor degenerated bioprostheses has been an indication for TAVI. However, this article reports a successful valve-in-valve implantation of a CoreValve aortic valve prosthesis through the right subclavian artery in a case of severe aortic regurgitation within a degenerated aortic homograft. The case exemplifies the possibilities of expanding the indications for TAVI, as well as other vascular access options than the femoral arteries.
Original language | English |
---|---|
Journal | Journal of Invasive Cardiology |
Volume | 21 |
Issue number | 10 |
Pages (from-to) | E197-200 |
ISSN | 1042-3931 |
Publication status | Published - 2009 |
Bibliographical note
Keywords: Aged, 80 and over; Aortic Valve; Aortic Valve Insufficiency; Calcinosis; Heart Catheterization; Heart Valve Prosthesis; Humans; Male; Transplants; Treatment Outcome
ID: 19868660